Description

This issue of Vital Signs, released on August 6, 2007, provides a strategic overview of the adaptation of life sciences research technologies in the production of biofuels. Additionally, a company spotlight is provided for Amyris Biotechnologies, a leader in synthetic biology applications for pharmaceuticals, nutraceuticals, biofuels and fine chemicals. Reimbursement and regulatory news from the FDA is also provided for the week of July 23 - July 27, 2007.